We are live on
!
Find out more
Mariner Portfolio holdings
AUM
$85.7B
1-Year Est. Return
24.21%
This Fund
S&P 500
This Quarter
Est. Return
+2.43%
1 Year Est. Return
+24.21%
3 Year Est. Return
+74.24%
5 Year Est. Return
+87.67%
10 Year Est. Return
+269.13%
AUM
$59.6B
AUM Growth
+$3.19B
(+5.7%)
Cap. Flow
+$2.58B
Cap. Flow
% of AUM
4.33%
Top 10 Holdings %
Top 10 Hldgs %
26.91%
Holding
3,565
New
280
Increased
1,859
Reduced
1,135
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$297M |
| 2 |
NVIDIA
NVDA
|
+$288M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$112M |
| 4 |
Apple
AAPL
|
+$108M |
| 5 |
Corning
GLW
|
+$105M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apollo Global Management
APO
|
+$237M |
| 2 |
Microsoft
MSFT
|
+$89.8M |
| 3 |
Ovintiv
OVV
|
+$80.5M |
| 4 |
Enphase Energy
ENPH
|
+$64.4M |
| 5 |
Walt Disney
DIS
|
+$38M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.31% |
| 3 | Consumer Discretionary | 6.42% |
| 4 | Healthcare | 5.15% |
| 5 | Communication Services | 4.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Globalstar
GSAT
$10.2B
| $29K | ﹤0.01% |
934
+221
| +31% | +$5.47K |
|
3327
Akebia Therapeutics
AKBA
$327M
| $28.4K | ﹤0.01% |
+14,944
| New | +$25.9K |
|
3328
Innoviz Technologies
INVZ
$135M
| $27.5K | ﹤0.01% |
16,390
+4,691
| +40% | +$3.88K |
|
|
PVL
3329
Permianville Royalty Trust
PVL
$56.1M
| $27K | ﹤0.01% |
+20,004
| New | +$30.7K |
|
|
KG
3330
Kestrel Group
KG
$71.3M
| $25.9K | ﹤0.01% |
765
-29
| -4% | -$927 |
|
|
NB
3331
NioCorp Developments
NB
$603M
| $25.3K | ﹤0.01% |
16,338
| – | – |
|
3332
Leslie's
LESL
$11.6M
| $25.2K | ﹤0.01% |
+565
| New | +$30K |
|
|
ICAD
3333
DELISTED
iCAD Inc
ICAD
| $24.7K | ﹤0.01% |
13,475
| – | – |
|
|
NBP
3334
NovaBridge Biosciences American Depositary Shares
NBP
$205M
| $24.4K | ﹤0.01% |
28,760
-2,775
| -9% | -$3.09K |
|
3335
Oxford Square Capital
OXSQ
$151M
| $24.4K | ﹤0.01% |
+10,010
| New | +$27.6K |
|
3336
Xilio Therapeutics
XLO
$56.9M
| $23.9K | ﹤0.01% |
1,786
-22
| -1% | -$303 |
|
3337
Chegg
CHGG
$108M
| $23.4K | ﹤0.01% |
14,545
-2,002
| -12% | -$3.69K |
|
|
SATX
3338
DELISTED
SatixFy Communications
SATX
| $22.9K | ﹤0.01% |
+15,000
| New | +$13.2K |
|
3339
Femasys
FEMY
$11.2M
| $20.6K | ﹤0.01% |
937
| – | – |
|
3340
Pyxis Oncology
PYXS
$165M
| $20.1K | ﹤0.01% |
+12,863
| New | +$37.1K |
|
3341
Alpha Tau Medical Warrant
DRTSW
$74.4M
| $19.7K | ﹤0.01% |
93,888
| – | – |
|
3342
Bolt Biotherapeutics
BOLT
$7.36M
| $18.7K | ﹤0.01% |
1,750
-277
| -14% | -$3.35K |
|
|
CLSD
3343
DELISTED
Clearside Biomedical
CLSD
| $18K | ﹤0.01% |
1,263
| – | – |
|
3344
Compugen
CGEN
$216M
| $17.9K | ﹤0.01% |
11,690
-81
| -0.7% | -$132 |
|
3345
United Maritime
USEA
$24.3M
| $17.3K | ﹤0.01% |
+10,002
| New | +$21.6K |
|
|
AMRN
3346
Amarin Corp
AMRN
$284M
| $13.9K | ﹤0.01% |
+1,432
| New | +$15.3K |
|
3347
Coherus Oncology
CHRS
$217M
| $13.8K | ﹤0.01% |
10,000
| – | – |
|
|
URG
3348
Ur-Energy
URG
$485M
| $13.8K | ﹤0.01% |
+11,998
| New | +$14.8K |
|
|
FABC
3349
Fabric.AI Inc
FABC
$16.8M
| $13.7K | ﹤0.01% |
1,250
| – | – |
|
3350
MIRA Pharmaceuticals
MIRA
$37.1M
| $13.1K | ﹤0.01% |
+11,500
| New | +$15K |
|
Similar funds
Mariner's Q4 2024 Portfolio in Review
As of Q4 2024, Mariner held 3,565 positions worth $59.6B, up 5.7% from $56.4B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Mariner deployed $2.58B of net new capital in Q4 2024, opening 280 new positions and adding to 1,859 existing holdings. Its largest new stake was Tempus AI: 923,786 shares worth $31.2M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apollo Global Management, an estimated $237M trimmed.
- Mariner's largest Q4 2024 buy was Tempus AI: 923,786 shares worth $31.2M.
- Mariner added most to Tesla in Q4 2024, an estimated $297M increase.
- Mariner's biggest Q4 2024 reduction was Apollo Global Management, cutting an estimated $237M.
- Mariner fully exited iShares iBonds Dec 2024 Term Corporate ETF in Q4 2024, selling an estimated $10.7M.
- Mariner's ten largest holdings make up 27% of its $59.6B portfolio in Q4 2024.
- Mariner opened 280 new positions and closed 187 in Q4 2024.
- Mariner's portfolio value rose 5.7% quarter-over-quarter to $59.6B.
Based on Mariner's 13F filing for Q4 2024, filed 13 Feb 2025.